These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8084859)

  • 21. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrops fetalis, thickened placenta and other sonographic findings in a low-level trisomy 21 mosaicism: a case report.
    Sifakis S; Koukoura O; Mantas N; Velissariou V; Koumantakis E
    Fetal Diagn Ther; 2008; 24(3):310-2. PubMed ID: 18832849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
    Valerio D; Aiello R; Altieri V; Fagnoni P
    Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
    Spencer K; Talbot JA; Abushoufa RA
    Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine death in singleton pregnancies with trisomy 21, 18, 13 and monosomy X.
    Goulart VV; Liao AW; Carvalho MH; Brizot Mde L; Francisco RP; Zugaib M
    Rev Assoc Med Bras (1992); 2016 Apr; 62(2):162-70. PubMed ID: 27167547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
    Hendricks SK; Sorensen TK; Baker ER
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of twin-twin transfusion syndrome complicated with hydrops fetalis at 14 weeks of gestation.
    Su RM; Yu CH; Chang CH; Yang HB; Chang FM
    Int J Gynaecol Obstet; 2001 May; 73(2):151-4. PubMed ID: 11336735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of partial trisomy 1q and monosomy X in a fetus with a congenital lung lesion and hydrops fetalis.
    Pressey TL; Wilson RD; Kasperski S; Bebbington MW; Adzick NS
    Am J Med Genet A; 2007 May; 143A(10):1104-7. PubMed ID: 17431907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased nuchal translucency, hydrops fetalis or hygroma colli. A new test strategy for early fetal aneuploidy detection.
    Jenderny J; Schmidt W; Hecher K; Hackelöer BJ; Kerber S; Kochhan L; Held KR
    Fetal Diagn Ther; 2001; 16(4):211-4. PubMed ID: 11399881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
    Benn PA; Horne D; Briganti S; Greenstein RM
    Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.